Clinical Trials on Újszülött herpesz

Total 570 results

Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

Prevention of : Herpes-Zoster
CLJI Worldwide
UMC Utrecht; University of Washington; University of Rotterdam, The Netherlands; Applied Clinical Services... and other collaborators

Completed

The VIBLOK SAfety and perFormancE Trial (SAFE)

Genital Herpes | HSV-2 Infection

Netherlands
Luminex Corporation

Completed

A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients

Herpes

United States
Naturopaths International

Completed

Hsv 1 and 2 Gowey Protocol Versus Placebo

Herpes

United States
New York State Psychiatric Institute
Alzheimer's Association

Active, not recruiting

Valacyclovir for Mild Cognitive Impairment (VALMCI)

Mild Cognitive Impairment | Herpes Simplex 2 | Herpes Simplex 1

United States
Heidelberg ImmunoTherapeutics GmbH

Completed

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection (MATCH-2)

Herpes Genitalis

Germany
Radboud University Medical Center

Completed

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID-I)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

Herpes Zoster
GlaxoSmithKline

Completed

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

Herpes Zoster

United States
National Institute of Allergy and Infectious Diseases...

Terminated

A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis

Herpes Labialis | Herpes Simplex Virus

United States
Novartis Pharmaceuticals

Completed

Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

Herpes Labialis

United States
Shulov Innovate for Science Ltd. 2012

Completed

Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores

Herpes Labialis

Israel
GlaxoSmithKline

Completed

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Herpes Genitalis

United States, Canada, Brazil, Argentina, Chile
Beech Tree Labs, Inc.
Norwich Clinical Research Associates Ltd.

Completed

Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

Oral Herpes Simplex

United States
Labo'Life

Recruiting

Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections. (HEARTH-OF)

Herpes Simplex

Belgium
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain

Herpes Zoster Pain

China
Labo'Life

Terminated

Study of 2LHERP® in Genital Herpes Infections (HEARTH-GEN)

Herpes Simplex, Genital

Belgium
Radboud University Medical Center

Terminated

Pharmacokinetics of Valacyclovir Oral Solution in Children (VALID2)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

Ulcers of Female Genital Organs

Zambia
University of Alabama at Birmingham

Completed

Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture

Herpes Simplex Virus

United States
Hologic, Inc.

Completed

Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

Herpes Simplex Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

VivaGel™ in Healthy Young Women

Herpes Simplex II

United States, Kenya
GlaxoSmithKline

Completed

Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

Prophylaxis Herpes Simplex

Belgium
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant

Prophylaxis Herpes Simplex

Belgium
Astellas Pharma Inc

Completed

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Herpes Genitalis

United States
NanoBio Corporation

Completed

Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Herpes Labialis

United States
Transport Pharmaceuticals

Completed

Iontophoretic Application of Acyclovir Gel to Treat Cold Sores

Herpes Labialis

United States
EyeGene Inc.
Novotech (Australia) Pty Limited

Completed

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers

Prevention of Herpes Zoster (HZ)

Australia
ContraVir Pharmaceuticals, Inc.

Completed

A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

Acute Herpes Zoster
GlaxoSmithKline

Terminated

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

Herpes Genitalis

United States, Australia, Hong Kong
Technische Universität Dresden
Beiersdorf AG

Completed

Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.

Herpes Simplex Labialis

Germany
NanoBio Corporation

Completed

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)

Recurrent Herpes Simplex Labialis

United States
Dominik Irnich

Completed

Acupuncture in Herpes Zoster Neuralgia (ACUZoster) (ACUZoster)

Pain | Herpes Zoster | Postherpetic Neuralgia

Germany
Fred Hutchinson Cancer Center
University of Washington; Sanofi Pasteur, a Sanofi Company

Completed

HSV529 Vaccine in HSV-2 Seropositive Adults

Herpes Simplex Virus 2

United States
Focus Diagnostics, Inc.

Completed

HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population

Herpes Simplex Virus 2

United States
Holdsworth House Medical Practice

Completed

Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes

HIV Positive | Herpes Simplex, Genital
Pfizer

Recruiting

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Shingles | Human | Herpes Zoster Infection

United States
Squarex, LLC

Completed

Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis (P2a)

Herpes Labialis | Cold Sore

United States
DeNova Research
Allergan

Terminated

Botulinum Toxin A for Herpes Labialis

Herpes Labialis

United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Palatability Testing of a New Paediatric Formulation of Valacyclovir (VALID-0)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
GlaxoSmithKline

Completed

Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease

Herpes Simplex
Integrative Medicine Institute
Beth Israel Medical Center; Southwest College of Naturopathic Medicine; Women... and other collaborators

Completed

Zinc for the Treatment of Herpes Simplex Labialis (HSL)

Herpes Simplex Labialis

United States
Radboud University Medical Center
GlaxoSmithKline

Completed

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Influenza | Herpes Zoster

Netherlands
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Genital Herpes

United States
University of Pisa
IRCCS Burlo Garofolo

Recruiting

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients

Herpesviridae Infections | Varicella Zoster Virus Infection | Transplantation Infection | Oncology | Herpes Simplex 1

Italy
Centers for Disease Control and Prevention
Johns Hopkins University; Massachusetts General Hospital; NYU Langone Health

Completed

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Genital Herpes

United States
aRigen Pharmaceuticals, Inc.

Unknown

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Herpes Zoster | Postherpetic Neuralgia

United States
Beech Tree Labs, Inc.
Norwich Clinical Research Associates Ltd.; Hill Top Research

Completed

Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores

Oral Herpes Simplex

United States
Innovative Molecules GmbH

Recruiting

Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers

Herpes Simplex Virus

Germany
China Academy of Chinese Medical Sciences

Unknown

Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome

Recurrent Aphthous Stomatitis | Intense-exuberant Stomach Fire Syndrom | Acute Pericoronitis | Recurrent Herpes Simplex Labialis

China

3

Subscribe